Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 15
Clinical Trial Report
TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,853 | Dovepress* | 6,520+ | 386 | 6,906 | |
| PubMed Central* | 333 | 105 | 438 | ||
| Totals | 6,853 | 491 | 7,344 | ||
| *Since 25 February 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar